Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-008250
Filing Date
2020-01-29
Accepted
2020-01-29 20:11:08
Documents
1
Period of Report
2020-01-28

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1510
  Complete submission text file 0001104659-20-008250.txt   2991
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Issuer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 360 HILLTOP RD PAOLI PA 19301
Business Address
McGroarty Jeffrey Brian (Reporting) CIK: 0001563273 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39202 | Film No.: 20559542